Contineum Therapeutics, Inc. (CTNM)
NASDAQ: CTNM · IEX Real-Time Price · USD
15.71
+0.21 (1.35%)
At close: May 20, 2024, 4:00 PM
15.40
-0.31 (-1.97%)
After-hours: May 20, 2024, 4:36 PM EDT
Contineum Therapeutics Statistics
Total Valuation
CTNM has a market cap or net worth of $394.80 million. The enterprise value is $277.48 million.
Market Cap | 394.80M |
Enterprise Value | 277.48M |
Important Dates
The last earnings date was Thursday, May 16, 2024, after market close.
Earnings Date | May 16, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
CTNM has 25.13 million shares outstanding.
Shares Outstanding | 25.13M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | n/a |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 7.90 |
Forward PS | n/a |
PB Ratio | n/a |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 5.55 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 19.20
Current Ratio | 19.20 |
Quick Ratio | n/a |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Capital (ROIC) | n/a |
Revenue Per Employee | $1.61M |
Profits Per Employee | -$14,419 |
Employee Count | 31 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
Beta (1Y) | n/a |
52-Week Price Change | n/a |
50-Day Moving Average | n/a |
200-Day Moving Average | n/a |
Relative Strength Index (RSI) | 55.20 |
Average Volume (30 Days) | 127,432 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, CTNM had revenue of $50.00 million and -$447,000 in losses. Loss per share was -$0.02.
Revenue | 50.00M |
Gross Profit | n/a |
Operating Income | n/a |
Pretax Income | n/a |
Net Income | -447,000 |
EBITDA | n/a |
EBIT | n/a |
Loss Per Share | -$0.02 |
Balance Sheet
The company has $117.91 million in cash and $585,000 in debt, giving a net cash position of $117.32 million or $4.67 per share.
Cash & Cash Equivalents | 117.91M |
Total Debt | 585,000 |
Net Cash | 117.32M |
Net Cash Per Share | $4.67 |
Equity / Book Value | -75.63M |
Book Value Per Share | -3.01 |
Working Capital | 113.48M |
Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | -0.89% |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
CTNM does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Earnings Yield | -0.11% |
FCF Yield | n/a |
Analyst Forecast
The average price target for CTNM is $28.00, which is 78.23% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $28.00 |
Price Target Difference | 78.23% |
Analyst Consensus | Strong Buy |
Analyst Count | 3 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |